NVTA Stock Invitae Corporation - Complete Overview
Nyse / Healthcare / Healthcare / NVTA Stock
|Avg Daily Volume||846.34K|
INVITAE CORPORATION (NVTA) OVERVIEW
NVTA stock is a healthcare company traded on Nyse. It is valued at 441.53M US dollars. There are 67.2M shares outstanding which Invitae Corporation issued to investors. Volatility of the stock is MEDIUM, and the daily volume is 57.56% stock on average. It brought investors a total return of -9.07% over the last 12 months. Invitae Corporation stock is relatively cheap. It's P/E ratio is below the market average.
Why This Genetics Stock Could Be a Gold Mine for Growth Investors
Invitae reported $1.6 million in revenue in 2014. This year it expects more than $130 million.
Here's Why Invitae Rose as Much as 13.9% Today
The company's first-quarter 2018 performance exceeded even its own lofty expectations.
Invitae's (NVTA) CEO Sean George on Q1 2018 Results - Earnings Call Transcript
Invitae (NYSE:NVTA) Q1 2018 Results Earnings Conference Call May 9, 2018, 04:30 PM ET Executives Laura D'Angelo - IR Sean George - CEO Shelly Guyer - CFO Lee Bendekgey - COO Katherine Stueland - Chief
Here's Why Invitae Stock Dropped as Much as 19.6% Today
The company priced its public offering of shares -- at an all-time low.
Market Movers Today: Twitter Inc (TWTR), Tesla Inc (TSLA), InVitae Corp (NVTA), InspireMD Inc (NSPR), and More
Shares of Twitter Inc. TWTR, -10.14% sank 5.2% toward a seven-week low in midday trade Tuesday, with losses accelerating after famed short seller Andrew...
This Explains Why Invitae Is Sinking Today
Traders head for the exits after the genetic testing company announces a dilutive capital raise.
|Price to Earnings||0.00||59.44||19.64||29.19|
|Price to Book Value||4.33||4.24||2.37||3.43|
|Price to Sales||5.16||3.40||1.45||3.27|
|Return on Equity||0.00%||14.08%||10.72%||15.27%|
|Return on Assets||0.00%||6.16%||5.79%||5.75%|